Key result
Having a serum extracellular superoxide dismutase (ecSOD) activity ≤ 98.8 U/ml was a strong and independent predictor of 1-year all-cause mortality in patients with AECOPD.
Why the study?
The association between serum extracellular superoxide dismutase (ecSOD) activity and 1-year all-cause mortality in patients with acute exacerbations of COPD (AECOPD) remains unclear.
Cohort (n=367)
No
Lower serum ecSOD activity (≤98.8 U/ml) on admission is a strong, independent predictor of 1-year all-cause mortality in patients hospitalized for acute exacerbations of COPD.
Answers are grounded in this paper and cite their sources.
Lower ecSOD activity may flag higher-risk AECOPD patients; hypothesis-generating for risk stratification, needs prospective validation.
Background and Objectives Accumulating evidence suggests that oxidative stress is involved in the development of chronic obstructive pulmonary disease (COPD) and its progression. Activity of extracellular superoxide dismutase (ecSOD), the only extracellular enzyme eliminating superoxide radicals, has been reported to decline in acute exacerbations of COPD (AECOPD). However, the association between serum ecSOD activity and 1-year all-cause mortality in AECOPD patients remains unclear. The objective of our study was to explore the usefulness of ecSOD activity on admission in AECOPD as an objective predictor for 1-year all-cause mortality. Methods We measured serum ecSOD activity in AECOPD patients on admission in a prospective cohort study. We also recorded their laboratory and clinical data. Multivariate Cox regression was used to analyze the association between ecSOD activity and the risk of 1-year all-cause mortality. Restricted cubic spline curves were used to visualize the relationship between ecSOD activity and the hazard ratio of 1-year all-cause mortality. Results A total of 367 patients were followed up for 1 year, and 29 patients died during a 1-year follow-up period. Compared with survivors, the non-survivors were older (79.52 ± 8.39 vs. 74.38 ± 9.34 years old, p = 0.004) and had increased levels of tobacco consumption (47.07 ± 41.67 vs. 33.83 ± 31.79 pack-years, p = 0.037). Having an ecSOD activity ≤ 98.8 U/ml was an independent risk factor of 1-year all-cause mortality after adjustment for baseline differences, clinical variables and comorbidities [hazard ratio = 5.51, 95% confidence interval (CI): 2.35–12.95, p < 0.001]. Conclusion Lower serum ecSOD activity was a strong and independent predictor of 1-year all-cause mortality in AECOPD patients.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a cohort in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) (n=367). Serum ecSOD activity ≤ 98.8 U/ml vs. Serum ecSOD activity > 98.8 U/ml was evaluated on 1-year all-cause mortality (HR 5.51, 95% CI 2.35-12.95, p=<0.001). Having a serum extracellular superoxide dismutase (ecSOD) activity ≤ 98.8 U/ml was a strong and independent predictor of 1-year all-cause mortality in patients with AECOPD.
Synapse has enriched 10 related papers. Consider them for comparative context: